Established in 1990, this Indian manufacturer employs approximately 3,065 individuals and specializes in developing and manufacturing IP-led niche finished dosage formulations. As a CTD dossier owner and manufacturer, it holds GMP certifications from major regulatory authorities, including the US FDA, EU-GMP, Health Canada, and UK MHRA, ensuring compliance with stringent international quality standards. The company operates eight manufacturing units across India, Singapore, Italy, the United States, and Kenya, producing a range of products, including soft gelatin capsules, tablets, and ointments. As a CTD dossier owner and manufacturer, its products are distributed in over 100 countries worldwide.

This CTD dossier owner and manufacturer operates under European standards and EU-GMP certification. They specialize in producing over 300 high-quality medicinal products distributed throughout their region of operation. Their focus areas include the genitourinary system, musculoskeletal system, respiratory system, nervous system, and alimentary tract & metabolism. They offer various dosage forms and utilize a multinational team of experts. Key strengths include investments in modern manufacturing facilities with specialized HP Zones for high-potency drugs, a commitment to research and development, and a strategic goal of expanding exports to both Asian and EU markets.